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Abstract.  We describe cDNA clones for a cell surface 
proteoglycan that bears both heparan  sulfate and chon- 
droitin  sulfate and that links the cytoskeleton to the in- 
terstitial matrix.  The eDNA encodes a unique core 
protein of 32,868 D  that contains several structural 
features consistent with its role as a glycosamino- 
glycan-containing matrix anchor.  The sequence shows 
discrete cytoplasmic, transmembrane,  and NH2- 
terminal extracellular domains,  indicating that the mol- 
ecule is a type I integral membrane protein.  The cyto- 
plasmic domain is small and similar in size but not in 
sequence to that of the/~-chain  of various integrins. 
The extracellular domain contains a  single dibasic se- 
quence adjacent to the extracellular face of the trans- 
membrane domain, potentially serving as the protease- 
susceptible site involved in release of this domain 
from the cell surface.  The extracellular domain con- 
tains two distinct types of putative glycosaminoglycan 
attachment sites; one type shows sequence characteris- 
tics of the sites previously described for chondroitin 
sulfate attachment (Bourdon, M.  A.,  T. Krusius, 
S.  Campbell,  N.  B.  Schwartz,  and E.  Ruoslahti.  1987. 
Proc. Natl. Acad.  Sci.  USA. 84:3194-3198),  but the 
other type has newly identified sequence characteris- 
tics that potentially correspond to heparan  sulfate at- 
tachment sites. The single N-linked sugar recognition 
sequence is within the putative chondroitin sulfate at- 
tachment sequence,  suggesting asparagine glycosylation 
as a mechanism for regulating  chondroitin sulfate 
chain addition.  Both 5' and 3' regions of this eDNA 
have sequences substantially identical to analogous 
regions of the human insulin receptor eDNA: a 99-bp 
region spanning the 5' untranslated  and initial  coding 
sequences is 67 % identical and a 35-bp region in the 
3' untranslated  region is 81%  identical in sequence. 
mRNA expression is tissue specific; various epithelial 
tissues show the same two sizes of mRNA (2.6 and 
3.4 kb); in the same relative abundance (3:1),  the cere- 
brum shows a  single 4.5-kb mRNA.  This core protein 
eDNA describes a new class of molecule, an integral 
membrane proteoglycan, that we propose to name syn- 
decan (from the Greek syndein,  to bind together). 
T 
HE cellular behavior responsible for the development, 
repair,  and  maintenance  of tissues  is  regulated,  in 
large part, by interactions  between the cells and their 
extracellular  matrix.  These interactions are mediated by cell 
surface molecules acting as receptors that bind the large in- 
soluble matrix molecules and induce responses that result in 
changes  of cellular phenotype. Several proteins associated 
with the cell surface can bind matrix components (Buck and 
Horwitz, 1987). These proteins differ in their specificity and 
affinity and in their mode of association with the cell surface. 
Some bind cells to single matrix ligands while others,  such 
as some members of the integrin super family (Hynes, 1987; 
Ruoslahti and Pierschbacher,  1987), appear to have multiple 
matrix ligands. Of the various matrix-binding  proteins at the 
cell surface, only the integrins are known to be integral mem- 
brane proteins.  Indeed, the integrin fibronectin receptor co- 
distributes both with extracellular  fibronectin and with intra- 
cellular cytoskeletal components (Chen et al., 1985; Damsky 
et al.,  1985), apparently  via an association of the receptors 
cytoplasmic domain with the cytoskeletal protein talin (Hor- 
witz et al.,  1986). 
We have been studying a lipophilic  proteoglycan contain- 
ing both heparan sulfate and chondroitin  sulfate (Rapraeger 
et al., 1985) that is found at the surface of mouse mammary 
epithelial  cells and that behaves as a high affinity receptor 
specific  for multiple  components of the interstitial  matrix. 
The proteoglycan binds the epithelial  cells via its heparan 
sulfate chains  to collagen  types I, III, and V (Koda et al., 
1985),  fibronectin  (Saunders  and  Bernfield,  1988),  and 
thrombospondin  (Sun, X. et al., 1989). When its extracellu- 
lar domain  (ectodomain)  is cross-linked at the cell surface, 
it  associates  intracellularly  with  the  actin  cytoskeleton 
(Rapraeger et al., 1986), and the isolated proteoglycan binds 
directly or indirectly  to F-actin  (Rapraeger  and Bernfield, 
1982).  Cultured  epithelial  cells shed the ectodomain from 
their  apical  surfaces as a  nonlipophilic  proteoglycan  that 
contains all of the glycosaminoglycan  of the intact molecule 
and polarize the proteoglycan exclusively to their basolateral 
surfaces (Rapraeger et al., 1986), a location consistent with 
its matrix receptor function.  Upon suspension of these cells, 
the ectodomain is cleaved from the cell surface; the proteo- 
glycan is not replaced while the cells are suspended (Jalka- 
nen et al., 1987). The proteoglycan is mainly on epithelia in 
mature tissues (Hayashi et al., 1987), and we have proposed 
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epithelial sheets by linking the cytoskeleton  to the extracellu- 
lar matrix (Bernfield et al.,  1985). 
The cell surface proteoglycan undergoes substantial regu- 
lation; its size,  glycosaminoglycan composition, and loca- 
tion at the cell surface vary between epithelial types, and its 
expression changes during development. The proteoglycan is 
located exclusively at the basolateral cell surface of simple 
epithelia but surrounds stratified epithelial cells (Hayashi et 
al., 1987). At basolateral cell surfaces, it appears to contain 
two heparan sulfate and two chondroitin sulfate chains, but 
where it surrounds cells, it contains only a single heparan 
sulfate chain and a  single small chondroitin sulfate chain 
(Sanderson and Bernfield, 1988). In self-renewing epithelial 
cell populations, such as the epidermis or vagina, the pro- 
teoglycan  is  lost  when  the  cells  terminally  differentiate 
(Hayashi et al., 1988). In embryos, the proteoglycan is tran- 
siently lost when epithelia change their shape and is transi- 
ently expressed by mesenchymal cells undergoing morpho- 
genetic tissue interactions (Thesleff et al., 1988; Trautman, 
M. S., J. Kimelman, and M, Bernfield, manuscript submit- 
ted for publication). 
Heparan sulfate proteoglycans are ubiquitous on the sur- 
faces of adherent cells and bind various ligands including ex- 
tracellular matrix, growth factors, proteinase inhibitors, and 
lipoprotein lipase (Fransson,  1987).  However,  no structure 
is known for the core protein of any such cell surface pro- 
teoglycan. Therefore, using a library from mouse mammary 
epithelial cells, we have molecularly cloned and sequenced 
full-length cDNAs for the cell surface proteoglycan matrix 
receptor and have assessed the expression of its mRNA in 
various  tissues.  The  311-amino  acid  core  protein  has  a 
unique  sequence  that  contains  several  structural  features 
consistent with its role as a matrix anchor and as an acceptor 
of two distinct types of glycosaminoglycan chains. The ex- 
pression of its mRNA is tissue type specific and both the 5' 
and 3' untranslated regions of its cDNA show substantial se- 
quence homology to those of the human insulin receptor 
cDNA. This core protein cDNA defines a new class of ma- 
trix receptor, an integral membrane proteoglycan, for which 
we propose the name syndecan (from the Greek syndein, to 
bind together). 
Materials and Methods 
c  D NA Libraries 
Normal murine mammary gland (NMuMG) I cells (passages 13-22) were 
maintained in bicarbonate-buffered DME (Gibco Laboratories,  Grand Is- 
land, NY) as previously described (David and Bernfield, 1979). For prepa- 
ration of poly(A) RNA, cells were plated on 245  x  245-mm tissue culture 
plates (Nunc, Roskilde, Denmark) at ~20%  confluent density and grown 
to 80-90% confluency (3-4 d). After brief washing with ice-cold PBS, the 
cells were solubilized in RNA extraction buffer (4 M  guanidine isothio- 
cyanate in 5 mM sodium citrate, pH 7.0, 0.1 M B-mercaptoethanol, and 0.5 % 
N-lauryl sarcosine), and total RNA was prepared by CsCI density centrifu- 
gation (Chirgwin et al., 1979). Poly(A) RNA was purified by chromatogra- 
phy on oligo(dT)-cellulose (type 3; Collaborative Research Inc., Waltham, 
MA) and used in the commercial synthesis (Stratagene,  La Jolla, CA) of 
eDNA by the S1 method (Huynh et al.,  1985). After the addition of Eco 
RI linkers, those eDNA >1 kb long were isolated by gel filtration chroma- 
tography, inserted into the Eco RI sites of 3` gt-10 and the expression vector 
1. Abbreviations used in this paper:  NMuMG,  normal murine mammary 
gland; TBST,  Tris-buffered saline/Triton. 
3, gt-ll, and packaged. A portion of the gt-ll library was amplified for later 
study, while the remainder was screened immediately without expansion. 
A  primer  extension cDNA  library was  prepared  using the  RNase  H 
method (Gubler and Hoffman,  1983). First-strand eDNA was synthesized 
from 10/~g liver poly(A) RNA (prepared as described below) using reverse 
transcriptase (Life Sciences Inc.,  St.  Petersburg, FL) specifically primed 
with  1 t~g of an 18-bp oligonucleotide containing sequence derived from 
near the 5' end of PM-4. The second strand was synthesized using RNase 
H  (Bethesda Research Laboratories,  Gaithersburg, MD) and DNA poly- 
merase Klenow fragment (Boehringer Mannheim Bioehemicals, Indianap- 
olis, IN). The eDNA was methylated with EcoRI methylase and then ligated 
with synthetic Eco RI linkers (New England Biolabs, Beverly, MA). Excess 
linkers were removed by Eco RI digestion and the eDNA was purified on 
agarose gel electrophoresis and recovered by electroelution. The resulting 
cDNA was inserted into 3` gt-10 (Promega Biotec, Madison, WI) and pack- 
aged using Giga pack Gold (Stratagene). 
Isolation of  cDNA Clones 
The preparation of a rabbit serum antibody to the ectodomain of NMuMG 
syndecan has been described elsewhere 0alkancn ¢t al., 1988). For screen- 
ing clones in k gt-ll, the immunoserum was first absorbed against Esche- 
richia coil proteins to reduce background. Briefly, a 500-ml culture of Esch- 
erichia coil strain Y1090 was grown to saturation in the presence of 50 
#g/ml ampicillin. After centrifugation, the cells were resuspended in 50 ml 
Tris-buffered saline/Triton (TBST, 10 mM Tris, pH 7, 150 mM NaCI, 0.3% 
Triton X-100), sonicated, and after addition of 100 ~1 immunoserum (1:500 
dilution), incubated overnight at 4°C. This mixture was centrifuged for 10 
min at 4,000 rpm and used to screen expressed 3, gt-ll eDNA clones (Young 
and Davis,  1983) by detection with alkaline phosphatase-conjugated goat 
anti-rabbit IgG (Promcga Biotec). Four antibody reactive clones were iden- 
tiffed and plaque purified. Northern and clonal Southern hybridization ex- 
periments allowed grouping of these clones into three distinct sets of related 
clones. Two of these sets produced fusion proteins that reacted with immu- 
noserum affinity purified against the ectodomain of syndecan. A clone from 
one of these  sets,  PM-4,  was  found to contain a  sequence that exactly 
matched the partial amino acid sequence of a cyanogen bromide-cleaved 
fragment of the ectodomain of syndecan. 
Additional screening of both the primer extended liver and NMuMG 3` 
gt-10 libraries was performed using radiolabeled fragments from the 5' end 
of PM-4.  eDNA fragments isolated from SeaPlaque agarose (FMC Bio- 
Products, Rockland, ME) were labeled with 32p by random oligonucleotide 
priming (Feinberg and Vogelstein, 1984) and used as described by Maniatis 
et al.  (1982). 
Subcloning and DNA Sequencing 
Purified  lambda DNA  was  prepared  from positively  selected clones by 
Lambdasorb  immunoprecipitation (Promega Biotec).  Fragments released 
by restriction endonuclease digestions were isolated by electrophoresis after 
excision from SeaPlaque agarose (FMC BioProducts). These isolated frag- 
ments were subcloned directly, in the presence of agarose (Struhl,  1985), 
to either pGEM 3 and 4 for in vitro transcription, or M13 mpl8 and mpl9 
(Messing,  1983) for sequence analysis. 
DNA  sequencing  was  performed  by  the  dideoxy  chain  termination 
method (Sanger et al.,  1977), using a modified T7 DNA polymerase (Se- 
quenase; United States Biochemical Corp., Cleveland, OH). Sequence was 
generated from both ends of subcloned restriction fragments using universal 
MI3 sequencing primers. The internal sequence of large fragments as well 
as the complementary strands of all fragments were determined using oligo- 
nucleotide primers synthesized in accordance with preceding sequences. 
Sequencing  artifacts  generated  as  the  result  of G-C  compression  were 
avoided by determining all sequences using both dGTP and the nucleotide 
analogue deoxyinosinetriphosphate (dITP). 
Northern Blots 
RNA  for Northern analysis was  prepared  from the following:  NMuMG 
cells, adult liver, newborn skin, midpregnant mammary gland, adult cere- 
brum, and skeletal and cardiac muscle.  Excised tissues were ground to a 
fine powder in the presence of liquid nitrogen and transferred directly to 
RNA extraction buffer (see above); the NMuMG cells were extracted after 
washing with PBS as described above. The samples were vigorously vor- 
texed, an equal volume of 10 mM Tris, pH 8.0,  1 mM EDTA, and 1% SDS 
added, and subsequently extracted exhaustively with 24:24:1 Tris-saturated 
phenol/chloroform/isoamyl  alcohol  followed by  a  single extraction with 
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61  CAG  TCGGGAGC  TGAC  TCCAGC  CGGCGAAAeC  TACAGCCC  TCGC  TCGAGAGAGCAGCGAGC 
121  TGGGCAGGAGCC  TGGGACAGCAAAGC  GCAGAGCAATCAGCAGAGCCGGCCCGGAGC TC  CG 
181  TGCAACCGGC~_~CTCGGATCCACGAAGCCCACCGAGCTCCCGCCGCCGGTCTGGC-CAC-CA 
M  1 
241  TGAGACGCGCGGCGCTCTGGCTCTGGC TCTGCGCGCTGGCGCTGCGCCTGCAGCC TGCCC 
R  R  A  A  L  W  L  W  L  C  A  L  A  L  R  L  Q  P  A  L  21 
301  TCCCGCAAATTGTGGCTGTAAATGTTCCTCCTGAAGATCAGGATGGCTCTGGGGATGAC  T 
P  Q  I  v  A  V  N  V  P  P  E  D  Q  D  G  S  G  D  D  S  41 
O 
361  CTGACAAC  TTC  TC  TGGCTCTGGCACAGGTGCTTTGCCAGATACTTTGTCACC-GCAGACAC 
D  N  F  S  G  S  G  T  G  A  L  P  D  T  L  S  R  Q  T  P  61 
•  O  O 
421  C  TTCCAC  TTGGAAGGACG  TGTGGC  TGT  TGACAGCCACGC  C  CACAGCTC  CAGAGCCCACCA 
S  T  W  K  D  V  W  L  L  T  A  T  P  T  A  P  E  P  T  S  81 
481  GCAGCAACACCGAGAC TGCTTTTACCTCTGTCCTGCCAGCCGGAGAGAAGCCCGAGGAGG 
S  N  T  E  T  A  F  T  S  V  L  P  A  G  E  K  P  E  E  G  101 
541  GAGAGC  C  TGTGC  TCCATGTAGAAGCAGAGCC TGGC  T  TCAC  TGC  TCGGGACAAGGAAAAGG 
E  P  V  L  H  V  E  A  E  P  G  F  T  A  R  D  K  E  K  E  121 
601  AGGTCACCACCAGGCCCAGGGAGACCGTGCAGCTCCCCATCACCCAACGGGCCTCAACAG 
V  T  T  R  P  R  E  T  V  Q  L  P  I  T  Q  R  A  S  T  V  141 
661  TCAGAGTCACCACAGCCCAGGCAGCTGTCACATC TCATCCGCACGGGGGCATGCAACC TG 
R  V  T  T  A  Q  A  A  V  T  S  H  P  H  G  G  M  Q  P  G  161 
721  GCC  TCCATGAGACC  TCGGCTCCCACAGCACCTGGTCAACCTGACCATCAGCCTCCACGTG 
L  H  E  T  S  A  P  T  A  P  G  Q  P  D  H  Q  P  P  R  V  181 
781  TGGAG~TGGC~CACTTCTGTCATCAAAGAGGTTGTCGAGGAT~AACTGCC~ATCA~ 
EGGGTSVIKEVVEDGTANQL201 
841  TTCCCGCA~AGAGGGCTCT~AG~CAAGACTTCACCTTTG~Q%ACATCTGGGGAG~CA 
PAGEGSGEQDFTFETSGENT221 
O  O 
901  CAGCTGTGGCTGCCGTAGA~CCGGCCTGCGG~TCA~CCCCGGT~ACGAAGGA~CA 
AVAAVEPGLRNQPPVDEGAT241 
961  CAGGTGCTTCTCAGK~CTTTT~ACAGGAAGGAAGTGCTGGGA~TCATTGCCGGAG 
GASQSLLDR~K~EVLGGVIAGG261 
1021  GCCTAGT~CTCATCTTT~TGTG~CCT~TGGCTTTCATGCTGTACCGGATGAAGA 
LVGLIFAVCLVAFMLYRMKK281 
1081  AGAA~ACGAAG~A~TACTCCTTGGAGGAGCCCAAACAAGCCAATG~GGT~CTACC 
KDEGSYSLEEPKQANGGAYQ301 
2141  AGAAACCCACC~A~A~AGTTCTACGCCTGAT~GGAAATAGTTCTTTCTCCCCCC 
KPTKQEEFYA*  311 
1201  CACA~CCCTGCCACTCACTAGGCTCCCACTT~CTCTTC~TGA~CTTCAAGCCCT 
1261  GGCCTCCCCACCACTGGGTCATGTCCTCT~ACCCAGGCCCTTCCA~TGTTCCT~CCG 
1321  AGC~TCCCAG~TGT~TGGGAACTGAT~CCC~CTTTGACT~T~CTAGAA~TTG 
1381  ~TGC~A~GTTTCTTGCATCTGATCTTTCTACCACAACCACACCTGTCGTCCAC~TT 
1441  CTGACTT~TT~CAAATG~AGGAGACCCAGCTCTGGACAGAAA~ACCCGACTG 
1501  CTTTGGACCTAGAT~CCTATTGC~CTGGA~ATCCTGA~ACAGGAGAGGGGCTTCGG 
1561  CTGACCA~CATA~ACTTACCCATAGAGACCGCTA~GTTGGCCGT~TGT~T~G~ 
1621  AT~A~CCTGAGCTCCTTGGAATCCACTTTTCATTGTGGGGA~TCTACTTTAGACAAC 
1681  TT~TTTT~ACATATTTTCTCTAATTTCTCTGTTCAGAGCCCCA~AGACCTTATTACT 
1741  GGGGTAAGC42~GTCTGTTGACT~TGTCCCTCACC~T~CCT~TCTACATTCA~ 
1801  AGACCGAA~GGG~TTAATAAGACTTTTTTTGTTT~TTTTTGTTTTTAACCTAG~ 
1861  GAACCAAA~TGGAC~CAAAACGTAGGCTTAGTTTGTGTGTTGTCTCTGAGTTTGTGCT 
1921  CAT~GTACAACAGGGTATGGACTATCTGTATGGT~CCCATTTTTGGCGGCCCGTAAGT 
1981  AGGCTAGGCTAGTCCAGGATAC~TGGAATA~CACCTCTTGACCAG~ATGCCTGTGTG 
2041  CATGGACTCAGGGCCACGGCCTTGGCCTGGGCCACCGTGACATT~AAGA~CTGTGTGA 
2101  GAACTTACTCGAAGTTCACAG~TA~AGTGGAGGGGA~AGAC~TAGAGTTTT~G~ 
2161  A~GGTA~AAGGGT~CCAA~GTCTCCCACCTTT~TACCATCTCTAGTCATCCTTCC 
2221  TCCC~AAGTTGACAAGACACATCTTGAGTATGGCTGGCACTGGTTCCTCCATCAAGAAC 
2281  CAAGTTCACCTTCAGCTCCTGTG~CCC~CCCUAG~TGGAG~AGAAATGTTTCCCAA 
2341  AGAG~AGTCTTTTGCTTTT~CAAAAC~TACTTAATCCAATGGGTTCTGTACAGTAGA 
2401  TTTT~AGATG~--A-A-A-A-A-A-A-A~CTTTAATATAAA~%2~ 
2461  AA 
Figure  1.  Sequence  of  syndecan  cDNA  clones,  corresponding 
amino acid sequence, and important structural ~atures. The pu~- 
tive  transmembrane  sequence  is  indicated  by  thick  underlining 
while  that  sequence  corresponding  to  the  experimentally  deter- 
mined peptide sequence is denoted by thin underlining. Glycosyla- 
tion  sites are  identified by  ci~les;  (o)  corresponds  to  potential 
glycosaminoglycan attachment si~s and (o) to a  po~ntial aspara- 
gine-linked glycosylation site. Arrows mark the putative site of ec- 
todomain cleavage from the cell sur~ce.  The polyadenylation sig- 
nal sequence AATAAA is boxed. 
24:1 chloroform/isoamyl  alcohol. After precipitation  with an equal volume 
of 2-propanol, and resuspension in 10 mM "Iris, pH 7.5, 1 mM EDTA, RNA 
was precipitated  by addition of 0.33 vol of 10 M LiCI.  Poly(A)  RNA was 
prepared by oligo d(T) chromatography as described above. 
For Northern analysis, 2/~g of each poly(A) RNA sample was separated 
by electrophoresis in !.2%  agarose-formaldehyde  gels  in the presence of 
MOPS (Sigma Chemical Co., St. Louis, MO) acetate buffer, pH 7.0 (Mania- 
tiset al., 1982). After alkali treatment (Danielsen et al., 1986) and neutral- 
ization in transfer buffer (0.025 M sodium phosphate, pH 6.5),  the gel was 
blotted to GeneScreen (New England Nuclear,  Boston, MA) and the RNA 
immobilized by UV cross-linking (Church and Gilbert, 1984). Hybridiza- 
tion probes were prepared by in vitro transcription of the 5' Eco RI-Sac I 
fragment of PM-4 subcloned into pGEM 3 (Melton et al., 1984). Blots were 
prehybridized  at 61°C in 50% formamide,  1% SDS, 5X SSPE, 0.1% ficoll, 
0.1% polyvinylpyrrolidone,  and 100 Atg/ml denatured salmon sperm DNA. 
Hybridization  was for 16 h at 61°C in the same buffer containing 5  x  106 
cpm/ml of RNA probe.  Filters were washed 2  ×  15 min at room tempera- 
ture in 5% SDS/IX SSPE and 6  x  30 min at 67°C in 1% SDS/0.1X SSPE. 
Molecular sizes were determined relative to ethidium bromide-stained mo- 
lecular mass markers (Bethesda Research Laboratories)  and 18-S and 28-S 
ribosomal RNA. 
Preparation and Use of  Antibodies to 
Synthetic Peptides 
A  7-amino  acid  (a4C-iabeled)  synthetic peptide,  corresponding to  the 
predicted  COOH terminus of syndecan  (Fig.  1), was generously provided 
by Dr. Russell Doolittle (University of California at San Diego). The NH2- 
terminal lysine of this peptide was cross-linked by glutaraldehyde to keyhole 
limpet hemocyanin (Calbiochem-Behring  Corp., San Diego, CA) for immu- 
nization and BSA (fraction %I, Sigma Chemical Co.) for screening as de- 
scribed by Doolittle (1986). Briefly, 10 nag carrier protein was dissolved in 
0.5 ml of 0.4 M phosphate,  pH 7.5, mixed with 7.5/~mol of peptide in 1.5 
ml water and 1.0 ml of 20 mM glutaraldehyde  (Ted Pella, Inc., Tustin, CA) 
was added dropwise with stirring over the course of 5 rain. After continuous 
stirring at room temperature for 30 rain, 0.25 ml of 1 M glycine was added 
to block unreacted glutaraldehyde and the stirring resumed for an additional 
30 rain. The product was dialyzed exhaustively against PBS and incorpora- 
tion determined by TCA precipitation  and liquid scintillation counting. This 
procedure resulted in the attachment of 17 mol of synthetic peptide/mole of 
carrier protein. 
For immunization, 1.25 mg of synthetic peptide-keyhole limpet hemocy- 
anin conjugate  in 0.5 ml PBS,  pH 7.5, was mixed  with 0.5  ml complete 
Freund's adjuvant (Gibco Laboratories).  The emulsion was delivered by in- 
tramuscular injections,  (3.1 ml in each of 10 sites,  into a 3-too-old  New 
Zealand white rabbit.  After 2 wk, the immunization was repeated  with an 
identical quantity of immunogen. I0 d later, the rabbit was injected with In- 
novar 0.125 ml/kg subcutaneously  and was bled from the central auricular 
artery.  Innovar was reversed  with Nalline 0.2 ml/kg, and serum was pre- 
pared from the collected  blood. 
The native lipophilic form of syndecan (Sanderson and Bernfield,  1988) 
and the nonlipophilic medium ectodomain form (Jalkanen et al., 1987) were 
isolated and purified as described elsewhere and assessed for their reactivity 
to the immune sera.  A cationic nylon membrane, GeneTrans (Plasco  Inc., 
Wohurn,  MA), was placed into an immunodot apparatus (V&P Scientific, 
San Diego, CA) and samples of intact syndecan  and the ectodomain  (0.5, 
5, 50, and 500 ng) were loaded on the membrane using mild vacuum. After 
loading,  remaining binding sites on the membrane were blocked by a  1-hr 
incubation in a solution containing 0.5 % BSA, 3 % Carnation instant nonfat 
dry milk, 10 mM "Iris (Sigma Chemical Co.), pH 8.0, 0.15 M NaC1, and 
0.3 % Tween-20. Incubation with immune serum was performed at dilutions 
of 1:200 for the anticytoplasmic  domain, and 1:500 for the antiectodomain 
in 10 mM "Iris, pH 7.4, 0.15 M NaCZ, and 0.3%  Tween-20 (TBST) for 30 
rain at room temperature.  The membrane was washed for 60 rain at room 
temperature with 10 changes of TBST and then incubated for 30 min with 
1:7,500 dilution of alkaline phosphatase goat anti-rabbit IgG (Promega Bio- 
tec). After washing for 60 min with 10 changes of TBST, the immobilized 
alkaline phosphatase was visualized  with nitro blue tetrazolium  (Promega 
Biotec)  330 p.g/ml and 5-bromo-4-chloro-3-indolyl phosphate (Promega 
Biotec)  165 /~g/ml in 100 mM Tris,  pH 9.5,  100 mM NaCI,  and 5 mM 
MgCI2. 
Results 
Isolation of Syndecan cDNA Clones 
Proteoglycan purified from normal murine mammary gland 
(NMuMG) cell-conditioned medium is both immunologi- 
cally (Jalkanen et al., 1987, 1988) and chemically (Jalkanen 
et  al.,  1987; Weitzhandler et  al.  1988)  indistinguishable 
from the trypsin-released ectodomain of syndecan. There- 
fore, we used a serum antibody directed against polypeptide 
determinants on this proteoglycan ectodomain to  identify 
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toplasmic domain distinguishes intact syndecan from the ectodo- 
main. Purified intact syndecan (A, C, and E) and the medium ec- 
todomain (B, D, and F) were loaded on Genetrans cationic nylon 
membrane at dilutions of  0.5, 5, 50, and 500 ng. The membrane was 
treated with sera and the bound antibody detected with alkaline 
phosphatase-conjugated anti-rabbit IgG. (A and B) Control serum; 
(C and D) anticytoplasmic domain serum; and (E and F) antiec- 
todomain serum. The anticytoplasmic domain serum reacts only 
with the intact syndecan molecule extracted from the cell surface, 
whereas the antiectodomain serum reacts both with the intact mole- 
cule and the nonlipophilic medium ectodomain. 
syndecan cDNA clones in a X gt-ll  expression library pre- 
pared from NMuMG cells. The unamplified portion of the 
NMuMG X gt-I1  cDNA library was initially screened with 
whole immune serum previously absorbed against host Y 
1090  Escherichia coli. Screening  of 7.5  x  1@  recom- 
binants yielded four positive cDNA clones.  Hybridization 
analysis  revealed  that  these  four  clones  represented  the 
cDNA of  three distinct gene products, only two of  which pro- 
duced  fusion  proteins  that  reacted  with  immune  serum 
affinity purified against the ectodomain of syndecan. One of 
these, PM-4, is a 2.1-kb clone that appears to code for the 
core protein of syndecan. 
Proof  of the identity of PM-4 was obtained by two indepen- 
dent methods. First, DNA sequence analysis revealed a de- 
rived protein sequence that matched the partial amino acid 
sequence of a cyanogen bromide-cleaved fragment of the ec- 
todomain of syndecan (Weitzhandler, 1988; Fig. 1). Second, 
syndecan purified from NMuMG cells reacted with an im- 
mune serum prepared against a synthetic peptide containing 
the COOH-terminal seven amino acids (Lys-Gln-Glu-Glu- 
Phe-Tyr-Ala) of the PM-4-derived protein sequence.  This 
immune serum failed to react with the ectodomain that lacks 
the putative cytoplasmic domain (Fig. 2). Furthermore, this 
serum does not cross-react with any other cellular proteins 
as assessed by Western blotting of total cell extracts (data not 
shown). 
Further  screening of  1.5  x  106  recombinants  from the 
amplified NMuMG ), gt-ll cDNA library produced no addi- 
tional positive clones. This might be explained by retarded 
growth of clones expressing the core protein caused by toxic 
influences on the growth of E. coli (Huynh et al.,  1985). In- 
deed,  infection with the  h  gt-ll  clone PM-4  consistently 
yielded low phage titers.  PM-4  was,  therefore, subcloned 
into a  plasmid vector (pUC-13)  to facilitate its  character- 
ization. 
Two approaches were used to isolate the complete coding 
region of syndecan.  First,  to  select clones containing  an 
extended 5' end,  a  X gt-10  cDNA  library prepared  from 
NMuMG cells was screened with a 250-bp Eco RI-Hinc II 
probe from the 5' end of PM-4. This screening yielded two 
clones,  4-19b  and 4-15,  which  were further characterized 
(Fig. 3). Second, a primer extended X gt-10 cDNA library, 
prepared with liver poly(A) RNA and a synthetic oligonu- 
cleotide complementary to a site near the 5' end of PM-4 (po- 
sitions 848-865 in Fig. 1), was screened with the same 250- 
bp Eco RI-Hinc II probe. Several independent clones were 
characterized from this library; each contained a 5' sequence 
identical with that of clone 4-19b (Fig.  3). 
Syndecan cDNA Sequence 
The clones were sequenced in M13 by the method of Sanger 
et al. (1977), using a strategy summarized in Fig. 3. The se- 
quence was established by sequencing both strands from a 
minimum of two of the independently isolated clones shown 
in Fig. 3. Because the syndecan cDNA contains a large num- 
ber of guanosine- and cytosine-rich regions, sequences were 
obtained with both dGTP and dlTP to avoid potential se- 
quencing artifacts caused by these regions. 
The cDNA (Fig.  1) has the following features. The first 
AUG  is  at position 240.  This putative initiation codon is 
preceded by two inframe termination codons (TAA and TGA 
at positions 39 and 72, respectively) and followed by a 930- 
base open reading frame that ends at position 1,173 with a 
TGA termination codon. Following the putative coding re- 
gion are  1,243  bases of 3' untranslated sequence that ends 
with the poly(A) addition sequence (AATAAA) followed 14 
bases later by a poly(A) stretch. Because each of the primer 
extended clones has the same 5' end as the largest cDNA 
clone from the  NMuMG  library,  M-4-19b,  this  sequence 
likely includes the complete 5' untranslated region of syn- 
decan. 
Syndecan Protein Structure 
Starting at the indicated AUG (Fig.  1), the syndecan eDNA 
codes for a protein of 311  amino acids containing two hy- 
drophobic stretches. This sequence corresponds with a pre- 
dicted molecular mass of 32,868 D and is unique; no statisti- 
cally significant similarities were detected when this sequence 
was compared with either the National Biomedical Research 
Foundation's Protein Sequence or the translated National In- 
stitutes of Health GenBank databases. The derived sequence 
suggests several domains and structural features; their pre- 
sumed arrangement is summarized in Fig. 6. 
The first hydrophobic stretch consists of 12 amino acids, 
including a cysteine, beginning shortly after the presumptive 
start methionine. Because syndecan is oriented with its NH2 
terminus outside of the plasma membrane (Weitzhandler et 
al., 1988), this hydrophobic sequence could represent a sig- 
nal peptide. The NH2 terminus of the mature syndecan core 
protein is blocked (Weitzhandler et al.,  1988), and, there- 
fore, it has not been possible to determine the NH2 termi- 
nus directly. A likely site for signal peptidase cleavage fol- 
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Figure 3.  Restriction map  and  se- 
quencing strategy of  syndecan cDNA 
clones. The size and orientation of 
syndecan cDNA clones 4-19 B, 4-15, 
PM-4, and the primer extended  clones 
are shown next to a restriction map of 
the cDNAs. The short arrows sum- 
marize the direction and length of se- 
quencing of various portions of the 
cDNAs. 
lows amino acid residue 17 (Fig.  1) in the predicted sequence. 
Cleavage at this site would generate an NH2-terminal gluta- 
mine that could readily cyclize forming a pyrrolidone car- 
boxylyl residue and thus a blocked NH2 terminus, as exists 
in a number of eukaryotic proteins (Allen,  1981). 
The second hydrophobic stretch is a  sequence near the 
COOH terminus that has characteristics of a transmembrane 
domain (Fig.  1, thick underline).  This sequence is a highly 
hydrophobic stretch of 25 residues followed immediately by 
a series of highly charged residues, consistent with the stop 
transfer signals  found following most membrane spanning 
domains (Sabatini et al.,  1982). This domain also contains 
the only cysteine and one of the four tyrosines in what we 
presume is the mature protein sequence. 
The putative transmembrane domain defines two hydro- 
philic domains of the syndecan core protein, a putative ex- 
tracellular domain consisting of "~ 235 amino acids, and a 
smaller putative cytoplasmic domain consisting of 34 amino 
acids. This orientation with respect to the plasma membrane 
is confirmed by the reactivity of immune serum directed ei- 
ther against a peptide containing the COOH-terminal seven 
amino  acids or against  the ectodomain of syndecan.  The 
anti-COOH-terminus immune serum recognizes the hydro- 
phobic native form of syndecan (Fig. 2 C) but is unreactive 
with the nonhydrophobic ectodomain (Fig. 2 D). In contrast, 
the anti-ectodomain immune serum recognizes both forms of 
the molecule (Fig. 2, E  and F). 
The putative cytoplasmic domain contains three tyrosine 
residues, but the sequences adjacent to these tyrosines are 
not similar to the presently identified consensus sequences 
for tyrosine phosphorylation (Hunter and Cooper,  1985). 
This domain presumably has protein binding activity be- 
cause the intact proteoglycan, but not the ectodomain, co- 
sediments with F-actin (Rapraeger and Bernfield, 1982) and 
because syndecan associates with the actin-containing cyto- 
skeleton when cross-linked at the cell surface (Rapraeger et 
al.,  1986). 
The putative extracellular domain has  several sequence 
characteristics that correspond with the known properties of 
this proteoglycan. The ectodomain of syndecan is shed by 
cleavage from its membrane anchor (Jalkanen et al.,  1987), 
and an indistinguishable molecule is released from the cell 
surface by mild trypsin treatment  (Jalkanen  et al.,  1987; 
Weitzhandler et al., 1988). The only dibasic sequence (Arg- 
Lys) in this extracellular domain is located adjacent to the 
putative transmembrane domain at residues 250-251 (Fig. 1, 
arrows). This location places the cleavage site adjacent to the 
plasma membrane. The putative extracellular domain lacks 
cysteine, thus eliminating disulfide bridges as a  means of 
generating secondary structure in this molecule. 
The ectodomain contains both heparan sulfate and chon- 
droitin sulfate chains (Rapraeger et al.,  1985). The serine 
hydoxyl group of ser-gly sequences are the attachment sites 
for these glycosaminoglycan chains  (Rod6n,  1980;  Dorf- 
man,  1981). Syndecan possesses five such potential glycos- 
aminoglycan attachment sites, all within the putative extra- 
cellular domain;  three such serines are clustered near the 
NH2 terminus at residues 37, 45, and 47, and the remaining 
two are clustered near the membrane at residues 207 and 217 
(Fig.  1, open circles). 
The ectodomain from NMuMG cells is insensitive to di- 
gestion by N-glycosidase F,  as assessed by PAGE (Weitz- 
handler  et  al.,  1988).  The putative  extracellular domain 
contains a single canonical sequence for the attachment of 
N-linked oligosaccharide (Fig. 1, solid circle). The serine in 
this Asn-Xaa-Ser sequence is the putative glycosaminogly- 
can attachment serine at position 45. 
Northern Blot Analysis of Syndecan Expression 
in Tissues 
Poly(A) RNA was prepared from NMuMG cells and a series 
of tissues (newborn skin, adult liver, midpregnant mammary 
gland, adult cerebrum, and adult skeletal and cardiac mus- 
cle). Immunohistological studies of  these tissues showed that 
the epithelial components of skin,  liver, and midpregnant 
mammary gland react with a monoclonal antibody (281-2) 
directed against the ectodomain, while cerebrum and striated 
muscle do not (Hayashi et al., 1987). Northern blot analysis 
of these  poly(A)  RNA  preparations  reveals  two  mRNA 
bands in NMuMG cells (Fig. 4 A) as well as in skin, liver, 
and mammary gland tissues (Fig. 4 B); one band is at 2.6 
and the other at 3.4 kb. The apparent lower level of expres- 
sion found in midpregnant mammary gland,  as compared 
with skin and liver, is consistent with the relative paucity of 
epithelial cells in the mammary gland. Longer exposures of 
the Northern blot shown in Fig. 4, as well as others contain- 
ing larger quantities of poly(A) RNA, verify that the mam- 
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cells (A) and several  tissues (B) were assessed for expression of  syn- 
decan mRNA. 2/zg of poly(A) RNA from each source was sepa- 
rated by electrophoresis  in 1.4% agarose-formaldehyde  gel in MOPS 
buffer, transferred, and hybridized as described in Materials and 
Methods. NMuMG cells, and liver, skin, and mammary gland tis- 
sue reveal messages at 2.6 and 3.4 kb. Hybridization to cerebral 
RNA reveals a unique message at 4.5 kb, while cardiac and skeletal 
muscle shows the absence of syndecan message. A and B represent 
4- and 15-h exposures, respectively. 
mary gland expresses both the 2.6- and the 3.4-kb messages 
(data not shown).  Scanning densitometry shows that these 
two messages are present at a nearly constant relative abun- 
dance of 3:1  (2.6 kb/3.4 kb) in NMuMG cells and in skin, 
liver, and mammary gland tissues (data not shown). As ex- 
pected from the immunohistology, neither of these mRNAs 
was present in detectable amounts in cerebrum and striated 
muscle tissues (skeletal and cardiac). Interestingly, however, 
Northern  analysis  consistently  detected a  distinct  4.5-kb 
mRNA in the cerebrum (Fig. 4 B). The relationship of this 
message to that of syndecan awaits  further investigation. 
Discussion 
We report here the first characterization of cDNA clones for 
an integral membrane proteoglycan that represents a class of 
multi-ligand matrix receptors. This proteoglycan, which we 
call syndecan (from the Greek, syndein, to bind together), 
binds cells to collagen types I, III, and V (Koda et al., 1985), 
fibronectin (Saunders and Bernfield,  1988), and thrombo- 
spondin (Sun, X. et al.,  1989). 
Size of the Syndecan Core Protein 
The derived protein sequence of syndecan is unique. Com- 
parisons with the National Biomedical Research Foundation 
and  the  translated  NIH-Genebank  databases  detected  no 
statistically significant similarities. The nascent polypeptide 
sequence is 311  amino acids and has a  molecular mass of 
32,868  D.  Treatment  of syndecan  with  heparitinase  and 
chondroitinase ABC generates a protein with relative mobil- 
ity of ~69 kD versus globular molecular mass markers on 
a  gradient  SDS-PAGE  system  (Sanderson  et  al.,  1988). 
Treatment of the ectodomain with anhydrous HF for 1.5 h at 
0°C  (Mort and Lamport,  1977),  yields a  protein that mi- 
grates  as  a  broad band  at  *46  kD  (Weitzhandler et al., 
1988).  These core protein sizes are  larger than would be 
predicted based on the cDNA and any incompletely removed 
carbohydrate. Syndecan is not a disulfide cross-linked dimer. 
Its migration on SDS-PAGE is unchanged after DTT treat- 
ment;  its cyanogen bromide cleavage product produces a 
single signal during amino acid sequencing; and the single 
cysteine in  the predicted mature protein is  located in  the 
transmembrane domain. It also does not appear to be cross- 
linked by lysyl oxidase- or transglutaminase-mediated reac- 
tions  because /3-aminopropionitrile (Franzblau  and  Faris, 
1982)  and  monodansylcadaverine (Bowness,  1987)  treat- 
ments of NMuMG cells do not change its mobility on SDS- 
PAGE in preliminary studies (data not shown). Proteins with 
regions rich in proline, alanine, and highly charged amino 
acids have highly extended conformations and anomalously 
slow mobilities in SDS-PAGE (Guest et al.,  1985).  These 
amino acids are abundant in syndecan and a Chou and Fas- 
man secondary structure prediction is consistent with large 
regions of extended conformation. In vitro translation of syn- 
thetic mRNA corresponding to the coding region of synde- 
can (Sac I-Hind III fragment of clone 4-19b) produces a na- 
scent polypeptide of ~45 kD (data not shown). Therefore, 
while we have not excluded the possibility of  other posttrans- 
lational modifications, the bulk of the size difference proba- 
bly reflects anomalous gel migration on SDS-PAGE. 
Syndecan Contains Distinct Functional Domains 
Cell biological studies of syndecan have implied three func- 
tional domains; an extracellular domain, and by inference, 
transmembrane  and  cytoplasmic domains  (Rapraeger  and 
Bernfield, 1985; Rapraeger et al., 1986). The amino acid se- 
quence derived from the syndecan cDNA demonstrates these 
domains directly. 
The transmembrane domain was inferred from the physi- 
cal properties of syndecan. Syndecan is mobile in the plane 
of the membrane (Rapraeger et al.,  1986) and is lipophilic, 
demonstrated by vectorial intercalation into liposomes (Ra- 
praeger and Bernfield, 1985), binding to hydrophobic mate- 
rials (Jalkanen et al.,  1987), and extraction with detergents 
(Rapraeger et al., 1986). However, lipophilicity does not as- 
sure that anchorage to the cell surface is via a transmembrane 
domain. Many proteins are anchored to the membrane via 
phosphatidyl inositol. Indeed, such an anchorage has been 
suggested for a proteoglycan on the surface of rat hepatocytes 
(Ishihara  et al.,  1987).  However, the derived COOH-ter- 
minal sequence of syndecan contains both a characteristic 
transmembrane domain and a 34-amino acid putative cyto- 
plasmic domain. These are not present in the proteins linked 
to  the  membrane by phosphatidyl  inositol (Ferguson and 
Williams,  1988). 
The cytoplasmic domain was inferred from properties in- 
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Syndecan co-sediments with F-actin (Rapraeger and Bern- 
field,  1982), resists detergent extraction from cells both at 
low pH and when cross-linked at the cell surface by antibod- 
ies,  and  colocalizes in polarized NMuMG  cells  with  the 
actin-containing cytoskeleton (Rapraeger et al.,  1986). An 
immune serum generated against a  synthetic peptide from 
the COOH-terminus of the derived protein sequence reacts 
with native syndecan extracted from NMuMG cells but not 
with the ectodomain (Fig. 2), providing direct evidence for 
the cytoplasmic domain. 
Syndecan and the #,-chain of integrin contain small cyto- 
plasmic domains, 34 and 47 amino acids, respectively (Tam- 
kun et al., 1986; Argraves et al., 1987), and both are thought 
to associate with the cytoskeleton after the binding of their 
extracellular matrix ligands (Chen et al.,  1985; Damsky et 
al.,  1985; Rapraeger et al.,  1986). The sequences of these 
domains show no obvious similarities, and the differences 
likely reflect distinct functions. It will be interesting to assess 
whether the cytoplasmic domains of various cell surface pro- 
teoglycans show the same extent of conservation as is found 
among the ~-chains of various integrins (Hynes,  1987). 
The ectodomain is released from NMuMG cell surfaces 
during cell culture, rapidly in response to cell rounding, or 
by mild trypsin treatment. The putative extracellular domain 
of syndecan contains a  single dibasic site near the plasma 
membrane at which cleavage of syndecan from the cell sur- 
face undoubtedly occurs. Because the endogenously shed ec- 
todomain of syndecan is indistinguishable from the trypsin- 
released form (Jalkanen et al.,  1987;  Weitzhandler et al., 
1988), a cell surface trypsinlike protease might be involved. 
Shedding during cell culture is from the apical surface of 
NMuMG  cells  and  is  markedly  reduced  when  syndecan 
polarizes to the basolateral surface (Saunders, S.,  and M. 
Bernfield, unpublished results). However, when these cells 
are released from the substratum, destroying their polarity, 
the ectodomain is rapidly shed. These results suggest that a 
cell surface protease is  involved and  identification of the 
putative cleavage site will now allow more detailed investiga- 
tion of this activity. 
Putative Attachment Sites for Heparan Sulfate and 
Chondroitin Sulfate 
Syndecan isolated from several sources is a hybrid proteo- 
glycan, containing both chondroitin sulfate and heparan sul- 
fate. These chains are linked via a xyloside to serine residues 
in proteins (Rodtn,  1980; Dorfman,  1981). Regulating the 
elaboration of both chondroitin sulfate and heparan sulfate 
chains on the same core protein is a significant problem be- 
cause the initial four saccharides are identical. The synthesis 
of  both types of chains is initiated by a xylosyltransferase that 
resides  in  either the  endoplasmic  reticulum or the  Golgi 
region (for review see Farquhar,  1985) and by three Golgi- 
localized glycosyltransferases (Geetha-Habib et al.,  1984). 
Specific chain elongation subsequently involves the sequen- 
tial action of an N-acetylgalactosaminyltransferase and a gluc- 
uronosyltransferase for chondroitin sulfate, and an N-acetyl- 
glucosaminyltransferase and  a  glucuronosyltransferase for 
heparan sulfate. This specific chain elongation must involve 
recognition of unique structural features of the core protein, 
indicating that distinct peptide sequences might exist at chon- 
droitin sulfate versus heparan sulfate attachment sites.  The 
presence of both chondroitin sulfate and heparan sulfate on 
syndecan provides the opportunity to assess the relationship 
between these attachment sites. Based on the core protein se- 
quence of three chondroitin sulfate proteoglycans (PG-19, 
PG-40, and invariant chain) and the reactivity of a xylosyl- 
transferase with  synthetic peptides,  Bourdon et al.  (1987) 
proposed that the xylose acceptor sequence for chondroitin 
sulfate in these proteoglycans is acidic-acidic-Xaa-Ser-Gly- 
Xaa-Gly. Syndecan contains five ser-gly sequences; the two 
in its single Ser-Gly-Ser-Gly  repeat closely match this accep- 
tor sequence (Fig.  5  A).  Interestingly, although this con- 
sensus acceptor sequence is located near the NH2 terminus 
of syndecan and near the COOH terminus of invariant chain, 
it is distant from the plasma membrane on both proteins. 
Syndecan contains three potential ser-gly glycosaminogly- 
can attachment sites that contain some features of this con- 
sensus acceptor sequence as well as unique features (Fig. 5 
B). Though each of these three sequences retains an acidic 
amino acid two residues NH2 terminal to the acceptor ser- 
gly,  they lack  the  consensus  glycine that  is  two  residues 
COOH terminal to the ser-gly. This omission does not pre- 
clude this sequence from serving as a xylosyltransferase ac- 
ceptor because it is also omitted from the gly-ser site of type 
IX collagen (Huber et al., 1988). The unique feature of  these 
three sequences is the consistent finding of an acidic amino 
acid COOH terminal to the ser-gly (Fig. 5 B). In contrast, 
the analogous amino acids  in the chondroitin sulfate pro- 
teoglycans PG-19,  PG-40, and invariant chain are either un- 
charged or hydrophobic. These three sites in syndecan may 
represent unique recognition sequences for the elongation of 
heparan sulfate chains. 
The number of chondroitin sulfate chains on syndecan ap- 
parently differs in cells of distinct cellular organization (San- 
derson  and  Bernfield,  1988)  and  changes  in  response to 
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Figure 5. Putative glycosylation sites of the syndecan core protein. 
The potential glycosaminoglycan  attachment sites of  the hybrid pro- 
teoglycan syndecan are compared with the known attachment sites 
of the chondroitin sulfate proteoglycans PG-19, PG-40, and invari- 
ant chain. The putative glycosylated serine in each case is indicated 
in bold. Identical or conserved substitutions of acidic residues have 
been boxed and the position of these residues in syndecan (see Fig. 
1) are in parenthesis. (A) The potential glycosylation site between 
residues 38-54 of syndecan shows the sequence Ser-Gly-Xaa-Gly 
with acidic residues NH2 terminal to the serine, strikingly similar 
to the consensus sequence described for attachment of chondroitin 
sulfate chains (Bourdon et al., 1987). The asterisk denotes the sin- 
gle potential N-linked glycosylation site. (B) The three remaining 
potential glycosylation sites of syndecan between residues 30-44, 
2130-214, and 210-224 are similar to each other and distinct from 
the proposed chondroitin sulfate attachment sites. These Ser-Gly 
are not followed  by Xaa-Gly and contain acidic residues both COOH 
and NH2 terminal to the serine. These sites are proposed to be 
heparan sulfate attachment sites. 
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Figure 6. Schematic structure of syndecan core protein. A structural organization is proposed for the syndecan core protein. Domains are 
indicated by boxes. The putative signal sequence is stippled, the extracellular domain open, the transmembrane  domain solid, and the cyto- 
plasmic domain diagonally striped. Potential glycosaminoglycan  attachment sites are indicated by the solid bars, and the single potential 
N-linked glycosylation site is indicated by an open bar and triangle. An arrow indicates the dibasic protease cleavage site, and the only 
cysteine and tyrosine residues in the predicted core protein are labeled. 
TGF-/~ (Rasmussen  and  Rapraeger,  1988),  implying that 
each potential glycosaminoglycan attachment site is not al- 
ways used. A possible novel regulatory mechanism for this 
variation is suggested by the location in syndecan of its single 
potential N-linked glycosylation site, Asn-Phe-Ser, at resi- 
dues 43-45. This site is located within the putative chondroi- 
tin sulfate attachment sequence, and the attachment of an 
N-linked sugar at this site would likely prevent subsequent 
recognition by the xylosyltransferase. 
Structural and Functional Relationship of Syndecan 
and lntegrins 
A  cell type can contain both syndecan and integrins, and 
these receptors can bind the cells to virtually identical matrix 
ligands (Saunders and Bernfield, 1988).  However, these re- 
ceptors are both structurally and functionally distinct. Syn- 
decan binds principally via its heparan sulfate chains, and, 
while the precise ligand binding sites on the integrins are not 
well defined, they are apparently generated by combinations 
of specific ct  and /3  chains  (Hynes,  1987; Ruoslahti and 
Pierschbacher,  1987). Whereas many of the matrix-binding 
integrins  bind  to  an  RGD-containing  sequence  (Piersch- 
bacher and Ruoslahti, 1984),  it is unknown whether synde- 
can binds to specific protein sequence(s).  Structurally, the 
integrins are heterodimers, and each oligomer is much larger 
than the single polypeptide of syndecan; however, both syn- 
decan and the integrins are transmembrane proteins contain- 
ing short cytoplasmic domains that associate with the actin 
cytoskeleton (Chen et al., 1985; Damsky et al., 1985; Rap- 
raeger et al.,  1986). 
Syndecan is present primarily on epithelial cells in mature 
tissues (Hayashi et al., 1987) but is also found on cells of the 
B-cell lineage (Sanderson, R., E  Lalor, and M. Bernfield, 
unpublished results) and can be expressed in embryonic and 
undifferentiated mesenchymal cells (Theselff, 1988;  Traut- 
man, M.  S., J.  Kimelman, and M.  Bernfield, manuscript 
submitted for publication). Integrins are expressed on these 
cells but also on a wide variety of hematopoietic precursor, 
mesenchymal, and neural cells (Buck and Horwitz,  1987). 
Cells can contain several integrins with seemingly redundant 
binding specificities and similar modes of transmembrane 
action. Why should these cells contain yet another class of 
matrix receptor with similar binding specificity and mode of 
action? We favor the hypotheses that (a) like the integrins, 
syndecan represents a collection of receptors that differ in 
their interactions because of their diverse number, type, and 
sequence of glycosaminoglycan chains, but that (b) matrix 
binding via the integrins and syndecans has a different role 
in regulating cell behavior. 
Interactions of cells with fibronectin indicate that binding 
via integrin and syndecan receptors can result in distinct cell 
behaviors. The fibronectin domain containing the sequence 
RGDS is recognized by an integrin and promotes cell adhe- 
sion; synthetic peptides containing this sequence interfere 
with cell-fibronectin interactions (Pierschbacher and Ruos- 
lahti, 1984). A heparin-binding domain near the COOH ter- 
minus is recognized by syndecan (Saunders and Bernfield, 
1988); synthetic peptides containing sequences from this site 
bind heparin directly and promote cell adhesion (McCarthy 
et al., 1988). Cell interactions with both the RGD-containing 
and heparin-binding domains are required for full elabora- 
tion of focal contacts and cytoskeletal organization (Izzard et 
al.,  1986; Woods et al.,  1986).  However,  focal contacts do 
not form on substrata containing a mixture of  the two isolated 
domains (Izzard et al., 1986). These results suggest that the 
integrin and  syndecan class  of receptors  cooperate  when 
bound to the same polypeptide. Because heparan sulfate in- 
duces a conformational change in fibronectin (Osterlund et 
al.,  1985),  this cooperation could result from changes in- 
duced by syndecan at the RGDS-containing domain. Based 
on several  such studies,  we have proposed  that syndecan 
stabilizes cell interactions with fibronectin-containing ma- 
trices, whereas the integrins are involved in initial recogni- 
tion and perhaps cell migration over such matrices (Saunders 
and Bernfield, 1988). 
The notion that syndecan mediates stable cell interactions 
with matrix is consistent with its structure. Because there are 
multiple putative heparan sulfate attachment sites,  a single 
syndecan molecule could have multiple interactions with ma- 
trix components via these glycosaminoglycan chains. This 
model could explain the high affinity  of syndecan for fibrillar 
collagen (Ko =  1 riM) (Koda et al.,  1985),  three orders of 
magnitude greater than the affinity of integrins (Buck and 
Horwitz, 1987).  Assuming a similar number of interacting 
receptors,  this affinity translates into exceedingly tight as- 
sociations that presumably are more physically stable than 
those mediated by lower affinity receptors.  The  syndecan 
structure also provides a unique mechanism to reduce the 
stability of the linkage: a putative protease-susceptible site 
adjacent to the transmembrane domain that allows its ex- 
tracellular domain to be cleaved from the cells thus releasing 
cells from the matrix. 
Syndecan Expression Is Tissue Specific 
Of a wide variety of mature tissues examined with antibody 
281-2, syndecan is expressed mainly in epithelia (Hayashi et 
al.,  1987).  Northern blot analysis of mRNA revealed two 
mRNA species at 2.6 and 3.4 kb (constant ratio 3:1, respec- 
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Gaps:  4  Similarity:  67% 
SYN  195 CGGATCCACGAAGCCCACCGAGCTCCCGCCGCCGGTCTGGGCAG~AGA  245 
I  lllIl  I  II  II  III  IIIIIII;  III  IIIIII  I  I  I 
HIR  107  CTGATCCGAGGAGACC*CCGCGCTCCCGCAGCC~***TT~GGCACCGGGGGC  153 
SYN  246  C*GCGCGGCGCTCTGGCTCTGGCTCTGCGCGCTGGCGCTGCGCCTGCAGC  294 
I  III  II  II  III  1  I  IIII  I  IIIII  II  I  II  II 
HIR  154  CGGCGGGGGGCGGCGGCCGCGCCGCTGCTGG*TGGCGGTGGCCGCGCTGC  202 
B 
Gaps:  0  similarity:  81% 
SYN  1816  TTAATAAGACTTTTTTTGTTTTTTGTTTTTGTTTTT  1851 
III  II  IIIIIIII  IIIIII  IIIII  IIIII 
HIR  4612  TTACAAATTCTTTTTII~I"I-x-iTTTTTTTTx-i-I-I-I"IT  4647 
Figure 7. DNA sequence similarities between murine syndecan and 
human  insulin receptor.  The DNA  sequence of the  5' untrans- 
lated-translational  start and 3' untranslated regions of syndecan 
(SYN) are highly similar with the same regions of  the human insulin 
receptor (HIR). Bestfit alignments of these sequences are indicated 
with asterisks marking gap nucleotides. (A) Positions 195-294 of 
the syndecan cDNA are 67% identical, allowing four small gaps 
(one 3-nucleotide and three single-nucleotide), with the compara- 
ble region of the human insulin receptor cDNA. The putative start 
ATGs of these two molecules are indicated by boxes. (B) Positions 
1,816 to 1,851 from the 3' untranslated region of the syndecan cDNA 
are 80% identical (no gaps) with a sequence from the 3' untrans- 
lated region of the human insulin receptor cDNA. 
tively) in NMuMG cells as well as skin, liver, and midpreg- 
nant mammary gland, all containing immunoreactive synde- 
can.  In  contrast,  these two mRNAs  were undetectable in 
cardiac and skeletal muscle, tissues of mesenchymal origin 
that do not stain with 281-2.  A 4.5-kb mRNA was detected 
in adult cerebrum, which does not react in fixed tissue sec- 
tions with the antibody (Hayashi et al.,  1987). 
The cDNA  sequence reported here corresponds to  the 
smaller  (2.6 kb)  and  more abundant  of the two mRNAs. 
Though the relationship between the 2.6- and 3.4-kb mRNAs 
is unknown, they are likely generated by usage of alternative 
polyadenylation sites.  Probes  from both 5' and  3' regions 
of the syndecan cDNA hybridized identically to these two 
mRNAs in Northern blot analysis (data not shown). More- 
over, the primer-extended library contained clones identical 
to the 5' end of clone 4-19B.  The relationship of the 4.5-kb 
mRNA identifed in cerebrum to the others is unknown be- 
cause clones have not yet been characterized from cerebral 
cDNA libraries. 
Untranslated Sequences Shared with Insulin 
Receptor cDNA 
Sequence alignments demonstrate a  remarkable similarity 
at the nucleotide level between the mouse syndecan and hu- 
man insulin receptor cDNA sequences (Ebina et al.,  1985). 
Alignment of these sequences (University of Wisconsin GCG 
Bestfit program) places the putative start ATGs near the mid- 
dle of a region of similarity; a 99-bp region of syndecan that 
spans its 5' untranslated and initial coding sequences is 67 % 
identical, with four small gaps, to the analogous region of 
the human insulin receptor (Fig. 7 A). The location of this 
similarity and the large size of the 5' untranslated regions 
suggest that these sequences are shared translational control 
elements, as has been described for the 5' untranslated region 
of the mRNAs for ferritin (Aziz and Munro, 1987; Casey et 
al.,  1988) and the B polypeptide of platelet-derived growth 
factor (Rather et al.,  1987). Remarkably, there is a second 
region of similarity between these cDNAs in their 3' untrans- 
lated regions; a 35-bp T-rich sequence of syndecan is 80% 
identical (no gaps)  with a  sequence of the human  insulin 
receptor (Fig. 7 B). These identical sequences in both 5' and 
3' untranslated regions between the mouse syndecan and hu- 
man  insulin  receptor mRNAs  suggest  that  posttranscrip- 
tional controls are shared by these two molecules. 
The immunohistology, derived structure, and mRNA anal- 
yses  are  consistent  with  syndecan's proposed  function of 
stabilizing epithelial sheets by anchoring the cells to the ma- 
trix. However, heparan sulfate proteoglycans are also known 
to bind growth factors. Basic fibroblast growth factor binds 
to heparan sulfate proteoglycans from endothelial cells (Sak- 
sela et al., 1988), an activity duplicated by syndecan. Trans- 
forming growth factor-~3 binds to the core protein of a hybrid 
cell surface proteoglycan found on a  variety of cell types 
(Segarini and Seyedin, 1988).  Because insulin is a known 
growth factor, the sequence similarity between the syndecan 
and insulin receptor cDNAs makes a growth factor binding 
function of syndecan more tenable. Binding of syndecan to 
interstitial matrix at the basolateral surface of simple epithe- 
lia might simultaneously anchor the cells to the matrix and 
serve as a sequestration point for growth factors at this cell 
surface. This multi  functionality might serve to integrate cel- 
lular behavior in response to growth factors and extracellular 
matrix. 
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